Your browser doesn't support javascript.
loading
TRIM68 negatively regulates IFN-ß production by degrading TRK fused gene, a novel driver of IFN-ß downstream of anti-viral detection systems.
Wynne, Claire; Lazzari, Elisa; Smith, Siobhán; McCarthy, Eoghan M; Ní Gabhann, Joan; Kallal, Lara E; Higgs, Rowan; Greco, Angela; Cryan, Sally Ann; Biron, Christine A; Jefferies, Caroline A.
Afiliación
  • Wynne C; Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland; School of Biological Sciences, Dublin Institute of Technology, Dublin, Ireland.
  • Lazzari E; Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Smith S; Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • McCarthy EM; Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Ní Gabhann J; Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Kallal LE; Department of Molecular Microbiology and Immunology, Brown University, Providence, Rhode Island, United States of America.
  • Higgs R; Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Cryan SA; School of Pharmacy, Royal College of Surgeons in Ireland, Dublin, Ireland; Trinity Centre for Bioengineering, Trinity College Dublin, Dublin, Ireland.
  • Biron CA; Department of Molecular Microbiology and Immunology, Brown University, Providence, Rhode Island, United States of America.
  • Jefferies CA; Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland.
PLoS One ; 9(7): e101503, 2014.
Article en En | MEDLINE | ID: mdl-24999993
ABSTRACT
In recent years members of the tripartite motif-containing (TRIM) family of E3 ubiquitin ligases have been shown to both positively and negatively regulate viral defence and as such are emerging as compelling targets for modulating the anti-viral immune response. In this study we identify TRIM68, a close homologue of TRIM21, as a novel regulator of Toll-like receptor (TLR)- and RIG-I-like receptor (RLR)-driven type I IFN production. Proteomic analysis of TRIM68-containing complexes identified TRK-fused gene (TFG) as a potential TRIM68 target. Overexpression of TRIM68 and TFG confirmed their ability to associate, with TLR3 stimulation appearing to enhance the interaction. TFG is a known activator of NF-κB via its ability to interact with inhibitor of NF-κB kinase subunit gamma (IKK-γ) and TRAF family member-associated NF-κB activator (TANK). Our data identifies a novel role for TFG as a positive regulator of type I IFN production and suggests that TRIM68 targets TFG for lysosomal degradation, thus turning off TFG-mediated IFN-ß production. Knockdown of TRIM68 in primary human monocytes resulted in enhanced levels of type I IFN and TFG following poly(IC) treatment. Thus TRIM68 targets TFG, a novel regulator of IFN production, and in doing so turns off and limits type I IFN production in response to anti-viral detection systems.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Autoantígenos / Virus / Proteínas / Interferón beta / Ubiquitina-Proteína Ligasas / Inmunidad Innata Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2014 Tipo del documento: Article País de afiliación: Irlanda

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Autoantígenos / Virus / Proteínas / Interferón beta / Ubiquitina-Proteína Ligasas / Inmunidad Innata Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2014 Tipo del documento: Article País de afiliación: Irlanda